Terms and Conditions

 

By accessing the MediTapRx website and related applications, and by using any of our services, you acknowledge that you have read, understood and agree to be bound by these Terms and Conditions. We reserve the right to update these Terms at any time, and any revisions will take effect upon publication on our website.

 

Section A – Introduction and General Terms

 

About Us

The MediTapRx website (meditaprx.co.uk) is owned and operated by HealthTap UK Ltd, a company registered in England and Wales (company number 16597038). “We” and “us” refer to HealthTap UK Ltd and our associated brands. Our clinical team comprises UK-registered pharmacists. We provide a telemedicine prescribing service and work with GPhC-registered partner pharmacies to dispense medications and related care or any community pharmacy of your choice.

 

Our Services

During a digital consultation (via questionnaire and telephone or video), our prescribers will discuss treatment options, which may include issuing a private prescription. There is no obligation to prescribe. If prescribing is deemed unsafe or inappropriate, the prescriber may decline and advise you to seek alternative care, for example, from your GP.

 

A questionnaire-based consultation or order for a POM, P or GSL medicine is an offer to purchase. It becomes a binding contract only when a prescription is issued or a service commences. We reserve the right to refuse orders that appear clinically unsafe or inappropriate. You acknowledge that prescribers decide whether to issue a prescription and that partner pharmacies handle dispensing and shipping.

 

Medicines displayed on our site are for illustrative purposes only. Access depends on a consultation and a valid private prescription, which is sent securely to our partner pharmacy for dispensing. MediTapRx does not store or dispense POM. P or GSL medications.

 

All services, products and prescriptions are intended solely for UK residents. If you access our services outside the UK, you do so at your own risk. Consultations must take place while you are physically in the United Kingdom.

 

 

Section B – Contact Us and Urgent Care

For enquiries, please contact us via:

• Email: admin@meditaprx.co.uk

• Live chat on our website

• Telephone: 07933-310401 (Mon–Sat, 08:00–20:00)

 

MediTapRx does not handle urgent or life-threatening emergencies. In emergencies:

• If life is at risk, call 999

• For non-life-threatening urgent care, call 111

• For minor injuries or out-of-hours GP services, call 111 or visit your nearest Minor Injuries Unit or A&E

 

Section C - Electronic Prescriptions and Dispensing

 

C.1 Prescription Issuance:
Electronic prescriptions issued by MediTapRx are genuine prescriptions prepared following a clinician’s assessment and issued in accordance with applicable UK law and professional guidance.

​

C.2 Prescription Transmission:
Prescriptions will be transmitted to the nominated dispensing pharmacy and, where applicable, to you using secure electronic messaging, secure links or other accepted secure transmission methods that employ appropriate encryption in transit and at rest.
 

We will use secure transport mechanisms consistent with healthcare industry standards and will maintain transmission and access logs sufficient for clinical governance and audit.

 

C.3 Prescription Validity:

Each electronic prescription remains valid for six months from the date of issue or for the period defined by applicable regulatory guidelines.

 

C.4 Patient Responsibilities

• Ensure your contact details and nominated pharmacy information are accurate and up to date.

• Present the electronic prescription (or unique prescription code) to your chosen pharmacy before dispensing.

• Notify us immediately if you believe the prescription has been sent in error or if you no longer require it.

 

C.5 Pharmacy Responsibilities

• Verify the authenticity and validity of the prescription in accordance with GPhC and RPS standards.

• Conduct any required identity checks and counselling before dispensing.

• Dispense only the exact medicine, strength, dosage form, and quantity specified unless a clinically appropriate generic equivalent is agreed.

 

C.6 Dispensing Fees and Co-payments

Any dispensing fees, private prescription charges, or pharmacy service fees are payable directly to the dispensing pharmacy and are not included in MediTapRx service prices.

 

C.7 Generic Substitution

Where permitted by law, a pharmacist may dispense a generic equivalent. The pharmacist will inform you of any substitution; we will update your prescription record accordingly.

 

C.8 Cancellation of Prescriptions

You may request cancellation or amendment of a prescription within 24 hours of issue. Suppose a prescription has already been transmitted to a pharmacy or dispensed. In that case, cancellation or amendment will be subject to the dispensing pharmacy’s policies and practical ability to recall or amend the supply.
 

Suppose a prescription is issued or transmitted in error. In that case, we will take reasonable steps to notify the nominated pharmacy and you and to mitigate any risk to patient safety, including facilitating recall where practicable.

 

C.9 Limitation of Liability

MediTapRx is not liable for any dispensing errors, delays, or clinical advice provided by third-party pharmacies. Any queries or complaints regarding dispensed medicines should be addressed directly with the dispensing pharmacy or, if unresolved, escalated to the General Pharmaceutical Council.

 

Section D – Privacy and Data Protection

 

We comply with the UK GDPR and the Data Protection Act 2018. MediTapRx clinicians act as data controllers and maintain records securely in line with Article 30 of the GDPR. You have the right to request a copy of the personal data we hold about you.

We share personal information only with third parties essential to service delivery, such as prescribers, partner pharmacies and couriers, and only with explicit consent for marketing purposes.

 

Our systems use SSL encryption to protect your data in transit. You agree to use appropriately secure devices to access our services. For full details, see our Privacy Policy.

 

D.1 Data controller and lawful bases
HealthTap UK Ltd (trading as MediTapRx) is the data controller for personal data processed in connection with the provision of services. Personal data, including special category health data, will be processed for the purposes of providing clinical care, fulfilling contractual and legal obligations, and, where required, with your explicit consent, in accordance with UK GDPR and the Data Protection Act 2018.

 

D.2 Purposes and categories of processing
We process identity, contact, clinical, prescription and transaction data to provide consultations, make prescribing decisions, facilitate dispensing, perform clinical audit and quality assurance, comply with legal and regulatory obligations, and to the extent you consent, for direct marketing. We will not process health data for marketing without your explicit consent.

 

D.3 Recipients and international transfers

We disclose personal data to partner pharmacies, clinicians, processors, couriers and other service providers where necessary to provide care. Processors are contractually bound to implement appropriate safeguards. Personal data will not be transferred outside the UK unless adequate safeguards are in place and you are informed of such transfers.

 

D.4 Data subject rights and how to exercise them
You have the right to access, rectify, erase, restrict processing, object to processing, and request portability of your personal data where applicable. Requests should be submitted to admin@meditaprx.co.uk. We will verify identity before complying with requests and will respond within statutory timescales.

 

D.5 Retention
Clinical records will be retained for a minimum of eight years from the date of last treatment, or longer where required by law or professional guidance. Non‑clinical records will be retained for periods proportionate to their purpose and legal obligations. Records will be securely deleted or anonymised when retention is no longer necessary.

 

D.6 Security and breach notification
We implement appropriate technical and organisational measures to protect personal data, including encryption, access controls, staff training and supplier due diligence. In the event of a personal data breach likely to result in risk to individuals, we will notify the Information Commissioner’s Office and affected individuals in accordance with legal requirements.

 

D.7 Data Protection Impact Assessment and contact
We have carried out or will carry out Data Protection Impact Assessments where processing is likely to result in high risk to individuals and will maintain records of processing activities. For data protection enquiries, to request a copy of our privacy documentation or the DPIA summary, contact admin@meditaprx.co.uk.

 

 

Section E – Account Registration

To use MediTapRx services, you must register an account with accurate personal details, including name, date of birth, medical history, and contact information. You must be 18 or over and the sole user of your account. You may cancel your account at any time by emailing admin@meditaprx.co.uk. We retain records for eight years post-treatment in line with UK healthcare standards. You may request earlier erasure in accordance with GDPR.

 

 

Section F – Identity Verification

​

We will verify the identity of every patient before providing clinical services or issuing prescriptions by means of documentary evidence (for example, a current passport, UK driving licence, or other government-issued photographic identity document) and/or electronic identity verification services.

 

Verification will be limited to the minimum personal data necessary to confirm identity and to fulfil our legal, regulatory and clinical obligations.

 

F.1 Lawful basis and purpose
The lawful bases for identity verification are: (a) performance of the contract for provision of healthcare services; (b) compliance with legal and regulatory obligations applicable to clinical care and prescribing; and (c) prevention and detection of fraud and abuse of clinical services.
 

Where identity checks require processing of special category data, such processing will be carried out on the basis of explicit consent and/or other lawful bases available under UK data protection law as required for clinical care and regulatory compliance.

 

F.2 Third‑party providers and data sharing
We may engage third‑party identity verification providers and, for that purpose, disclose only the minimum personal data necessary for verification. Such providers will act as our processors and will be subject to written data processing agreements that require appropriate technical and organisational safeguards.
 

We will not perform credit scoring or other activities that adversely affect your credit rating as part of routine identity verification. Where a third‑party check may involve financial data, we will notify you and obtain explicit consent before proceeding.

 

F.3 Retention, correction and review

Identity verification records will be retained only for as long as is necessary for clinical governance, regulatory compliance, fraud‑prevention, or other lawful purposes and will thereafter be deleted or archived in accordance with our Data Retention Policy.
 

You may request correction of identity data by contacting admin@meditaprx.co.uk. If verification cannot be satisfactorily completed, we may refuse to provide services or issue prescriptions; you may supply additional evidence for reconsideration.

 

 

Section G – Professional Standards and Regulation

 

Our clinicians and service partners are regulated by the UK professional body (GPhC).

 

They follow standards for person-centred care, professional judgement, confidentiality, and remote prescribing guidelines. Prescribers operate within their scope of practice and refer you elsewhere if a condition falls outside their competence.

 

We do not prescribe Schedule 2 or 3 controlled medications, including but not limited to: morphine, tramadol, pregabalin, temazepam, and similar drugs or require specialist monitoring. For questions on standards, contact us.

​

Section H – Patient Obligations

 

When using MediTapRx services, you agree to:

• Inform your GP of any treatments or advice received

• Provide honest, complete and accurate information

• Do not misuse your account or consult on behalf of others

• Read all patient information leaflets before using medications

• Store medications safely and follow expiry dates

• Seek clarification if you do not understand any instructions, consultation questions or website information

• Report serious adverse reactions immediately and stop using the product, as well as inform the prescriber and partner pharmacy

 

You may also report side effects via the MHRA Yellow Card Scheme: https://www.yellowcard.mhra.gov.uk.

 

 

Section I – Prices and Payment

 

All prices are in GBP and include VAT. Payments must be made by bank transfer only; we will provide the bank account details after your consultation and before issuing a prescription. We reserve the right to withhold the prescription until payment has been received. The account name is under HealthTap UK, Ltd, the registered company of MediTapRx.

 

If a price error occurs, we may cancel the prescription and refund any difference necessary for a fair transaction.

​

Section J – Advertising Compliance

 

All communications about MediTapRx must comply with ASA and MHRA Blue Book guidance. Public content must focus on the service and patient experiences, not on specific prescription medicines. Non-compliant or misleading advertising may result in suspension from promotional programmes or forfeiture of benefits.

​

Section K – Medication Errors

 

Despite rigorous processes, errors can occur. We operate a no-blame culture to investigate and learn from mistakes. If you receive an incorrect or unsafe medication, contact us immediately. Seek medical advice if you experience any harm, and in emergencies, call 999.

​

Section L – Digital Consultation and Data Consent

 

By using our digital consultation service, you agree that we will collect, record, store and use your identity and health information to provide safe clinical consultations and to support lawful dispensing, with processing carried out in accordance with UK data protection law, including the UK GDPR and the Data Protection Act 2018.

 

We will keep your information in secure clinical systems and use it solely for your direct clinical care unless you provide additional, explicit consent for other uses; you have the right to withdraw consent and to be told how your data will be used in clear, prominent terms as set out in ICO guidance on consent.

 

We will verify prescriber registration with the appropriate UK healthcare regulators as part of safe clinical governance and to meet our legal and professional obligations under healthcare confidentiality and regulatory frameworks.

 

Your information will be treated as confidential and will not be shared except where you give explicit consent, where disclosure is necessary to prevent serious harm, or where otherwise required or permitted by law; disclosures to your GP or other care providers will only occur with your explicit consent unless exceptional circumstances apply under common law confidentiality and statutory powers.

 

Section M – Liability

 

M.1 Professional responsibility and insurance
MediTapRx clinicians accept professional responsibility for clinical assessments and prescribing decisions made through MediTapRx. MediTapRx and its clinicians maintain professional indemnity and insurance in levels required by applicable regulatory bodies.

 

M.2 Limitation of liability
2.1. Subject to clause 3 below, MediTapRx’s aggregate liability to you for loss or damage arising out of or in connection with these Terms, whether in contract, tort (including negligence), misrepresentation or otherwise, shall be limited to direct, reasonably foreseeable losses and shall not exceed £1,000,000 per claim or series of connected claims, unless a higher limit is required by law or professional regulatory obligations.

 

M.3 Non‑excludable liabilities
3.1. Nothing in these Terms excludes or limits liability for death or personal injury resulting from our negligence, liability for fraud or fraudulent misrepresentation, or any other liability that cannot be excluded or limited by law.

 

M.4 Third‑party pharmacy liability
4.1. Dispensing, counselling and supply of medicines are the responsibility of the dispensing pharmacy. MediTapRx is not liable for dispensing errors, delays, or clinical advice provided by a third‑party pharmacy except where such loss or damage results directly from MediTapRx’s negligent act or omission in issuing or transmitting clinical information or prescriptions.

 

M.5 Patient indemnity
5.1. You agree to indemnify and hold harmless MediTapRx against any loss, liability, cost or expense (including reasonable legal costs) arising from your breach of these Terms, your provision of false or misleading information, failure to inform your GP, follow prescribed advice or your misuse of the service, except to the extent that such loss arises from MediTapRx’s negligence or breach of these Terms.

 

M.6 Claims notice and limitation period
6.1. All claims shall be notified in writing to admin@meditaprx.co.uk as soon as reasonably practicable and, except where statute provides otherwise, no later than 12 months from the date on which you became aware of the circumstances giving rise to the claim.

 

Section N – Complaints and Feedback

 

We welcome feedback and aim to resolve complaints promptly. To provide feedback or lodge a complaint, email admin@meditaprx.co.uk with “Feedback” or “Complaint” in the subject line. We will acknowledge in writing within 7 working days and work with you towards a resolution.

 

 

Section O – Referral Letters

 

We can supply referral letters to other healthcare professionals for a fee of £30. Request by emailing admin@meditaprx.co.uk. Letters are provided by email within 7 working days.

 

 

Section P – Fit Note

 

We can issue a fit note only for conditions we’ve consulted on or treated; retrospective notes for undiagnosed issues aren’t possible. Fit notes are available once you’ve been off work for more than seven days (including your self-certification period) and cover up to 14 days. If you need an extension beyond 14 days, you’ll need to see your GP. Each fit note costs £30 per letter and is non-refundable.

 

Section Q - Telephone and Video Consultations

 

Consultation fees cover the consultation service only and do not include the cost of any medications or products. Telephone or video consultations may be offered at our discretion and will incur the applicable consultation fee.

Video consultations will use secure, end-to-end encrypted platforms such as Zoom or WhatsApp, selected for patient convenience. Consultation durations are as specified for the chosen service (15 minutes or 30 minutes). If a consultation exceeds its allotted time, an automatic 15-minute extension will be provided at no extra charge; thereafter an additional fee of £5 will apply for each further 15-minute period.

 

Section R – Appointment Cancellation

 

Cancel at least 48 hours before your scheduled telephone or video appointment for a full refund or rescheduling. Cancellations within 48 hours are non-refundable but may be rescheduled. To cancel or reschedule, email admin@meditaprx.co.uk.

 

 

Section S – Age and Location

​

Services are available only to individuals aged 18 or over, resident in and physically present within the United Kingdom at the time of consultation.

 

 

Section T – Cookies

 

We use necessary cookies to operate our website securely and personalise your experience. By continuing to browse, you consent to our Cookie Policy. You may disable cookies via your browser settings, but this may affect website functionality.

 

Section U – Third Party Rights

 

No third party has the right to enforce any provision of these Terms under the Contracts (Rights of Third Parties) Act 1999.

 

Section V – Waiver

 

Failure or delay by us in enforcing any right under these Terms does not constitute a waiver of that right on future occasions.

​

Section W – Governing Law and Jurisdiction

 

These Terms are governed by English law. Any disputes arising under or in connection with these Terms will be subject to the exclusive jurisdiction of the courts of England and Wales.

​

Last reviewed: 28 October 2025